Center for Health Care Evaluation, VA Palo Alto Healthcare System, Menlo Park, CA 94025, USA.
Pain Med. 2010 Apr;11(4):575-85. doi: 10.1111/j.1526-4637.2010.00818.x. Epub 2010 Mar 1.
To develop and evaluate a clinical decision support system (CDSS) named Assessment and Treatment in Healthcare: Evidenced-Based Automation (ATHENA)-Opioid Therapy, which encourages safe and effective use of opioid therapy for chronic, noncancer pain.
CDSS development and iterative evaluation using the analysis, design, development, implementation, and evaluation process including simulation-based and in-clinic assessments of usability for providers followed by targeted system revisions.
Volunteers provided detailed feedback to guide improvements in the graphical user interface, and content and design changes to increase clinical usefulness, understandability, clinical workflow fit, and ease of completing guideline recommended practices. Revisions based on feedback increased CDSS usability ratings over time. Practice concerns outside the scope of the CDSS were also identified.
Usability testing optimized the CDSS to better address barriers such as lack of provider education, confusion in dosing calculations and titration schedules, access to relevant patient information, provider discontinuity, documentation, and access to validated assessment tools. It also highlighted barriers to good clinical practice that are difficult to address with CDSS technology in its current conceptualization. For example, clinicians indicated that constraints on time and competing priorities in primary care, discomfort in patient-provider communications, and lack of evidence to guide opioid prescribing decisions impeded their ability to provide effective, guideline-adherent pain management. Iterative testing was essential for designing a highly usable and acceptable CDSS; however, identified barriers may limit the impact of the ATHENA-Opioid Therapy system and other CDSS on clinical practices and outcomes unless CDSS are paired with parallel initiatives to address these issues.
开发并评估名为“医疗保健评估和治疗:基于证据的自动化(ATHENA-阿片类药物治疗)”的临床决策支持系统(CDSS),鼓励安全有效地使用阿片类药物治疗慢性非癌痛。
使用分析、设计、开发、实施和评估过程开发和迭代评估 CDSS,包括基于模拟和临床评估的可用性,供提供者使用,然后进行有针对性的系统修订。
志愿者提供了详细的反馈,以指导图形用户界面、内容和设计的改进,以提高临床实用性、可理解性、临床工作流程适应性以及完成指南推荐实践的易用性。基于反馈的修订随着时间的推移提高了 CDSS 的可用性评分。还确定了 CDSS 范围之外的实践问题。
可用性测试优化了 CDSS,以更好地解决障碍,如缺乏提供者教育、剂量计算和滴定方案混淆、获取相关患者信息、提供者连续性、文档和获取经过验证的评估工具。它还突出了一些难以通过 CDSS 技术在其当前概念化中解决的良好临床实践障碍。例如,临床医生表示,初级保健中时间和优先事项竞争的限制、患者-提供者沟通的不适以及缺乏指导阿片类药物处方决策的证据,阻碍了他们提供有效、符合指南的疼痛管理的能力。迭代测试对于设计高度可用和可接受的 CDSS 至关重要;然而,确定的障碍可能会限制 ATHENA-阿片类药物治疗系统和其他 CDSS 对临床实践和结果的影响,除非 CDSS 与并行举措相结合,以解决这些问题。